薬理遺伝学的検査の世界市場レポート 2025

薬理遺伝学的検査市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR15.8％で257億7,000万米ドルに成長します。予測期間の成長は、バイオテクノロジーとヘルスケアに関連する研究開発の増加、ヘルスケア支出の増加、慢性疾患の有病率の上昇、アクセスビリティの向上、遠隔医療とデジタルヘルスの台頭に起因すると考えられます。予測期間における主な動向としては、薬理遺伝学的検査、ゲノム技術の進歩、技術の進歩、コンパニオン診断の進歩、革新的な診断検査などが挙げられます。

個別化医療に対する需要の高まりが、当面の薬理遺伝学的検査市場の成長を牽引すると予測されます。精密医療とも呼ばれる個別化医療は、患者一人ひとりの特性に合わせて医療上の意思決定や治療をカスタマイズするヘルスケアアプローチです。個別化医療への注目が高まる背景には、治療成績の向上、予防や早期発見の重視、費用対効果の向上など、複数の要因が影響しています。薬理遺伝学的検査は、個人の遺伝的体質を調べ、特定の薬に対する反応を予測することで、個別化医療において重要な役割を果たしています。これにより、ヘルスケアプロバイダーは遺伝的要因に基づいて治療をカスタマイズし、薬効を最適化し、副作用を最小限に抑えることができます。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、FDAが希少疾患患者向けに新規の個別化治療を2022年の6件から2023年には16件承認したと報告しました。このように、個別化医療に対する需要の高まりが薬理遺伝学的検査市場の成長を後押ししています。

薬理遺伝学検査分野の主要企業は、処方箋ベースの薬理遺伝学的検査のような最先端の薬理遺伝学検査サービスを提供し、競争力を確立しようとしています。処方箋に基づく薬理遺伝学的検査は、ヘルスケアプロバイダーが患者の遺伝子プロファイルを分析するために、薬の処方に先立って特別に注文または処方する遺伝子検査です。例えば、2023年5月、米国のヘルスケア機関であるUCSFは、治療の精度を高めることを目的としたファーマコゲノミクス検査サービスを導入しました。このサービスは、医療提供者が個人の遺伝子プロファイルに従って薬物療法を調整するのを支援するもので、薬効を向上させ、副作用を減らし、個別化医療戦略を強化することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界薬理遺伝学的検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の薬理遺伝学的検査市場：成長率分析
• 世界の薬理遺伝学的検査市場の実績：規模と成長, 2019-2024
• 世界の薬理遺伝学的検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界薬理遺伝学的検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の薬理遺伝学的検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全ゲノム配列解析
• 全エクソームシークエンシング
• 配列ベースのテスト
• 単一遺伝子検査
• 世界の薬理遺伝学的検査市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方薬
• 栄養補助食品
• 娯楽用薬物
• ハーブサプリメント
• ビタミン
• 市販薬
• 世界の薬理遺伝学的検査市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓病学
• 消化器内科
• 麻酔科
• ゲノミクス
• 内分泌学
• 免疫学と過敏症
• 皮膚科
• 婦人科
• 腫瘍学
• その他の治療領域
• 世界の薬理遺伝学的検査市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• 通信販売薬局
• 顧客直販サービス
• 世界の薬理遺伝学的検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヘルスケア提供者
• 製薬およびバイオテクノロジー企業
• センターおよび学術機関
• その他のエンドユーザー
• 世界の薬理遺伝学的検査市場全ゲノムシーケンシングのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• イルミナシーケンシング
• イオントレントシーケンシング
• パシフィック・バイオサイエンス・シーケンシング
• オックスフォードナノポアシーケンシング
• 世界の薬理遺伝学的検査市場全エクソームシーケンシングのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• キャプチャベースのエクソームシーケンシング
• ターゲットエンリッチメントエクソームシーケンシング
• ハイブリダイゼーションベースのエクソームシーケンシング
• 世界の薬理遺伝学的検査市場アレイベーステストの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• SNPアレイテスト
• 表現配列のテスト
• コピー数多型アレイ検査
• 世界の薬理遺伝学的検査市場単一遺伝子検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的遺伝子パネル
• 変異検出検査
• 特定遺伝子の配列決定

第7章 地域別・国別分析

• 世界の薬理遺伝学的検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の薬理遺伝学的検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 薬理遺伝学的検査市場：競合情勢
• 薬理遺伝学的検査市場：企業プロファイル
  • CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Precision Medicine Advisors
• Azenta Life Sciences
• Fulgent Genetics
• Pacific Biosciences of California Inc.
• Castle Biosciences
• 23andMe Holding Co.
• Helix Inc.
• Genomind Inc.
• MD Labs
• Sonic Genetics
• AutoGenomics Inc.
• LabClinics SA
• Gene By Gene Ltd.
• Xcode Life Sciences
• YouScript

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 薬理遺伝学的検査市場2029：新たな機会を提供する国
• 薬理遺伝学的検査市場2029：新たな機会を提供するセグメント
• 薬理遺伝学的検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmacogenetic testing is a specialized form of genetic testing that evaluates how an individual's genetic profile affects their response to specific medications, facilitating the customization of drug treatments to enhance efficacy and minimize side effects. This personalized approach significantly improves patient care by aligning therapies with genetic characteristics. It finds extensive application in areas such as oncology, psychology, and cardiology.

The primary types of pharmacogenetic testing include whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing is a thorough method that analyzes the entire genome of an individual, sequencing all DNA in a single test to provide a comprehensive view of genetic information. The scope of drugs assessed includes prescription medications, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter products across various therapeutic areas, such as cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and others. These products are distributed through hospital pharmacies, retail pharmacies, mail-order services, and direct-to-consumer channels, serving diverse end users including healthcare providers, pharmaceutical and biotechnology companies, research centers, and academic institutions.

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides pharmacogenetic testing market statistics, including pharmacogenetic testing industry global market size, regional shares, competitors with a pharmacogenetic testing market share, detailed pharmacogenetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. This pharmacogenetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $12.37 billion in 2024 to $14.35 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing overall drug efficacy, increasing adoption of personalized medicine, growing need for precision diagnosis, increasing focus on pharmacogenetic testing, and increasing medical expenses.

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $25.77 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to rising research and development associated with biotechnology and healthcare, increasing healthcare expenditure, rising prevalence Of chronic diseases, increased accessibility, rise of telemedicine and digital health. Major trends in the forecast period include pharmacogenetic testing, advancements in genomic technologies, technological advancements, advances in companion diagnostics, and innovative diagnostic tests.

The rising demand for personalized medicine is anticipated to drive growth in the pharmacogenetic testing market in the foreseeable future. Also referred to as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments to align with the individual characteristics of each patient. The growing focus on personalized medicine is influenced by multiple factors, including improved treatment outcomes, an emphasis on prevention and early detection, and enhanced cost-effectiveness. Pharmacogenetic testing plays a crucial role in personalized medicine by examining an individual's genetic makeup to predict their response to specific medications. This allows healthcare providers to customize treatments based on genetic factors, optimizing drug efficacy and minimizing adverse effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the pharmacogenetic testing market.

Leading companies in the pharmacogenetics testing sector are advancing their offerings with cutting-edge pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to establish a competitive edge. Prescription-based pharmacogenetic testing involves genetic tests specifically ordered or prescribed by healthcare providers to analyze a patient's genetic profile prior to medication prescriptions. For example, in May 2023, UCSF, a US-based healthcare organization, introduced its pharmacogenomics testing service aimed at enhancing the precision of medical treatments. This service assists healthcare providers in tailoring drug therapies according to an individual's genetic profile, with the objective of improving drug efficacy, reducing adverse reactions, and bolstering personalized medicine strategies.

In May 2023, HealthOme, a US-based company specializing in advanced genetic testing and personalized medicine solutions, acquired Kailos Genetics for an undisclosed sum. This acquisition aims to strengthen HealthOme's genetic testing and personalized medicine capabilities by integrating Kailos Genetics' advanced genomic technologies and expertise. Kailos Genetics is a US-based firm that offers comprehensive pharmacogenetic testing services through its Inspexion platform.

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacogenetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacogenetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Whole Genome Sequencing; Whole Exome Sequencing; Array-Based Tests; Single Gene Tests
• 2) By Drug Type: Prescription Drugs; Nutraceuticals; Recreational Drugs; Herbal Supplements; Vitamins; Over-The-Counter Medications
• 3) By Therapeutic Area: Cardiology; Gastroenterology; Anesthesiology; Genomics; Endocrinology; Immunology And Hypersensitivity; Dermatology; Gynecology; Oncology; Other Therapeutic Areas
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Mail-Order Pharmacies; Direct-to-Customer Services
• 5) By End User: Healthcare Providers; Pharmaceutical And Biotechnology Companies; Centers And Academic Institutes; Other End Users
• Subsegments:
• 1) By Whole Genome Sequencing: Illumina Sequencing; Ion Torrent Sequencing; Pacific Biosciences Sequencing; Oxford Nanopore Sequencing
• 2) By Whole Exome Sequencing: Capture-Based Exome Sequencing; Targeted Enrichment Exome Sequencing; Hybridization-Based Exome Sequencing
• 3) By Array-Based Tests: SNP Array Testing; Expression Array Testing; Copy Number Variation Array Testing
• 4) By Single Gene Tests: Targeted Gene Panels; Mutation Detection Tests; Sequencing Of Specific Genes
• Companies Mentioned: CVS Health Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Eurofins Scientific Inc.; Bio-Rad Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacogenetic Testing Market Characteristics

3. Pharmacogenetic Testing Market Trends And Strategies

4. Pharmacogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmacogenetic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmacogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmacogenetic Testing Market Growth Rate Analysis
• 5.4. Global Pharmacogenetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmacogenetic Testing Total Addressable Market (TAM)

6. Pharmacogenetic Testing Market Segmentation

• 6.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Genome Sequencing
• Whole Exome Sequencing
• Array-Based Tests
• Single Gene Tests
• 6.2. Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Nutraceuticals
• Recreational Drugs
• Herbal Supplements
• Vitamins
• Over-The-Counter Medications
• 6.3. Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiology
• Gastroenterology
• Anesthesiology
• Genomics
• Endocrinology
• Immunology And Hypersensitivity
• Dermatology
• Gynecology
• Oncology
• Other Therapeutic Areas
• 6.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacies
• Mail-Order Pharmacies
• Direct-to-Customer Services
• 6.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Healthcare Providers
• Pharmaceutical And Biotechnology Companies
• Centers And Academic Institutes
• Other End Users
• 6.6. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Illumina Sequencing
• Ion Torrent Sequencing
• Pacific Biosciences Sequencing
• Oxford Nanopore Sequencing
• 6.7. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capture-Based Exome Sequencing
• Targeted Enrichment Exome Sequencing
• Hybridization-Based Exome Sequencing
• 6.8. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• SNP Array Testing
• Expression Array Testing
• Copy Number Variation Array Testing
• 6.9. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Gene Panels
• Mutation Detection Tests
• Sequencing Of Specific Genes

7. Pharmacogenetic Testing Market Regional And Country Analysis

• 7.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacogenetic Testing Market

• 8.1. Asia-Pacific Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacogenetic Testing Market

• 9.1. China Pharmacogenetic Testing Market Overview
• 9.2. China Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacogenetic Testing Market

• 10.1. India Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacogenetic Testing Market

• 11.1. Japan Pharmacogenetic Testing Market Overview
• 11.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacogenetic Testing Market

• 12.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacogenetic Testing Market

• 13.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacogenetic Testing Market

• 14.1. South Korea Pharmacogenetic Testing Market Overview
• 14.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacogenetic Testing Market

• 15.1. Western Europe Pharmacogenetic Testing Market Overview
• 15.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacogenetic Testing Market

• 16.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacogenetic Testing Market

• 17.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacogenetic Testing Market

• 18.1. France Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacogenetic Testing Market

• 19.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacogenetic Testing Market

• 20.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacogenetic Testing Market

• 21.1. Eastern Europe Pharmacogenetic Testing Market Overview
• 21.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacogenetic Testing Market

• 22.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacogenetic Testing Market

• 23.1. North America Pharmacogenetic Testing Market Overview
• 23.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacogenetic Testing Market

• 24.1. USA Pharmacogenetic Testing Market Overview
• 24.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacogenetic Testing Market

• 25.1. Canada Pharmacogenetic Testing Market Overview
• 25.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacogenetic Testing Market

• 26.1. South America Pharmacogenetic Testing Market Overview
• 26.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacogenetic Testing Market

• 27.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacogenetic Testing Market

• 28.1. Middle East Pharmacogenetic Testing Market Overview
• 28.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacogenetic Testing Market

• 29.1. Africa Pharmacogenetic Testing Market Overview
• 29.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

• 30.1. Pharmacogenetic Testing Market Competitive Landscape
• 30.2. Pharmacogenetic Testing Market Company Profiles
  • 30.2.1. CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacogenetic Testing Market Other Major And Innovative Companies

• 31.1. Precision Medicine Advisors
• 31.2. Azenta Life Sciences
• 31.3. Fulgent Genetics
• 31.4. Pacific Biosciences of California Inc.
• 31.5. Castle Biosciences
• 31.6. 23andMe Holding Co.
• 31.7. Helix Inc.
• 31.8. Genomind Inc.
• 31.9. MD Labs
• 31.10. Sonic Genetics
• 31.11. AutoGenomics Inc.
• 31.12. LabClinics SA
• 31.13. Gene By Gene Ltd.
• 31.14. Xcode Life Sciences
• 31.15. YouScript

32. Global Pharmacogenetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

34. Recent Developments In The Pharmacogenetic Testing Market

35. Pharmacogenetic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Pharmacogenetic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmacogenetic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmacogenetic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer